Literature DB >> 16455195

BRCA1 and BRCA2 germline mutations in Korean breast cancer patients at high risk of carrying mutations.

Sei Hyun Ahn1, Byung Ho Son, Kyung-Sik Yoon, Dong-Young Noh, Wonshik Han, Sung-Won Kim, Eun Sook Lee, Hai-Lin Park, Young Joon Hong, Jae Jin Choi, Seo Yun Moon, Mi Jeong Kim, Kye Hyun Kim, Beom Seok Kwak, Dae-Yeon Cho.   

Abstract

We analyzed the mutation spectrum of BRCA1 and BRCA2 genes in 354 Korean breast cancer patients. Overall, 40 patients carried 25 distinct BRCA1/2 mutations including 12 novel mutations. Seven district mutations were found in multiple unrelated patients, with the BRCA2 c.7480C>T mutation detected in eight unrelated patients, accounting for 50% of the mutations detected in BRCA2. The large number (25/40, 62.5%) of recurrent mutations suggests the possibility of developing a simple screening test for these mutations. The frequency of mutations was related to the number and kinds of risk factors, varying from 10.4 to 25% in the five major risk factor groups. The frequency of BRCA mutations in patients with two or more risk factors was markedly higher than that in patients with one risk factor.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16455195     DOI: 10.1016/j.canlet.2005.12.031

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  19 in total

Review 1.  Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countries.

Authors:  Ava Kwong; Vivian Y Shin; John C W Ho; Eunyoung Kang; Seigo Nakamura; Soo-Hwang Teo; Ann S G Lee; Jen-Hwei Sng; Ophira M Ginsburg; Allison W Kurian; Jeffrey N Weitzel; Man-Ting Siu; Fian B F Law; Tsun-Leung Chan; Steven A Narod; James M Ford; Edmond S K Ma; Sung-Won Kim
Journal:  J Med Genet       Date:  2015-07-17       Impact factor: 6.318

2.  Heterozygous germline mutations in NBS1 among Korean patients with high-risk breast cancer negative for BRCA1/2 mutation.

Authors:  Haeyoung Kim; Dae-Yeon Cho; Doo Ho Choi; Gee Hue Jung; Inkyung Shin; Won Park; Seung Jae Huh; Sung-Won Kim; Sue K Park; Jong Won Lee; Seok Jin Nam; Jeong Eon Lee; Won Ho Gil; Seok Won Kim
Journal:  Fam Cancer       Date:  2015-09       Impact factor: 2.375

3.  BRCA1 and BRCA2 germline mutations in Korean ovarian cancer patients.

Authors:  Myong Cheol Lim; Sokbom Kang; Sang-Soo Seo; Sun-Young Kong; Bo-Yon Lee; Seon-Kyung Lee; Sang-Yoon Park
Journal:  J Cancer Res Clin Oncol       Date:  2009-06-05       Impact factor: 4.553

4.  Contribution of the BRCA1 and BRCA2 mutations to breast cancer in Tunisia.

Authors:  Wafa Troudi; N Uhrhammer; C Sibille; C Dahan; W Mahfoudh; C Bouchlaka Souissi; T Jalabert; L Chouchane; Y J Bignon; F Ben Ayed; A Ben Ammar Elgaaied
Journal:  J Hum Genet       Date:  2007-10-09       Impact factor: 3.172

5.  Genomic Sequencing for Newborn Screening: Results of the NC NEXUS Project.

Authors:  Tamara S Roman; Stephanie B Crowley; Myra I Roche; Ann Katherine M Foreman; Julianne M O'Daniel; Bryce A Seifert; Kristy Lee; Alicia Brandt; Chelsea Gustafson; Daniela M DeCristo; Natasha T Strande; Lori Ramkissoon; Laura V Milko; Phillips Owen; Sayanty Roy; Mai Xiong; Ryan S Paquin; Rita M Butterfield; Megan A Lewis; Katherine J Souris; Donald B Bailey; Christine Rini; Jessica K Booker; Bradford C Powell; Karen E Weck; Cynthia M Powell; Jonathan S Berg
Journal:  Am J Hum Genet       Date:  2020-08-26       Impact factor: 11.025

6.  Performance of BRCA1/2 mutation prediction models in Asian Americans.

Authors:  Allison W Kurian; Gail D Gong; Nicolette M Chun; Meredith A Mills; Ashley D Staton; Kerry E Kingham; Beth B Crawford; Robin Lee; Salina Chan; Susan S Donlon; Yolanda Ridge; Karen Panabaker; Dee W West; Alice S Whittemore; James M Ford
Journal:  J Clin Oncol       Date:  2008-09-08       Impact factor: 44.544

7.  Accuracy of BRCA1/2 mutation prediction models for different ethnicities and genders: experience in a southern Chinese cohort.

Authors:  Ava Kwong; Connie H N Wong; Dacita T K Suen; Michael Co; Allison W Kurian; Dee W West; James M Ford
Journal:  World J Surg       Date:  2012-04       Impact factor: 3.352

8.  Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: the Korean Hereditary Breast Cancer (KOHBRA) Study.

Authors:  Byung Ho Son; Sei Hyun Ahn; Sung-Won Kim; Eunyoung Kang; Sue K Park; Min Hyuk Lee; Woo-Chul Noh; Lee Su Kim; Yongsik Jung; Ku Sang Kim; Dong-Young Noh; Byung-In Moon; Young Jin Suh; Jeong Eon Lee; Doo Ho Choi; Sung Yong Kim; Sung Hoo Jung; Cha Kyong Yom; Hyde Lee; Jung-Hyun Yang
Journal:  Breast Cancer Res Treat       Date:  2012-03-02       Impact factor: 4.872

9.  Associations between BRCA Mutations in High-Risk Breast Cancer Patients and Familial Cancers Other than Breast or Ovary.

Authors:  Jae Myoung Noh; Doo Ho Choi; Hyejin Baek; Seok Jin Nam; Jeong Eon Lee; Jong Won Kim; Chang-Seok Ki; Won Park; Seung Jae Huh
Journal:  J Breast Cancer       Date:  2012-09-28       Impact factor: 3.588

10.  Methylation of BRCA1 promoter region is associated with unfavorable prognosis in women with early-stage breast cancer.

Authors:  Nicholas C Hsu; Ya-Fang Huang; Kazunari K Yokoyama; Pei-Yi Chu; Fang-Ming Chen; Ming-Feng Hou
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.